What the business is, and whether it's a good one at a fair price.
Manufactures chlor-alkali and downstream specialty chemicals at its Dahej, Gujarat facility. Caustic soda is the base product; most of the chlorine produced on-site is consumed captively to make epichlorohydrin (ECH), CPVC, chloromethanes, hydrogen peroxide and chlorotoluene. Derivatives and specialty chemicals contributed 48% of FY26 revenue, with a stated target of 70% by FY28E. For FY26, the business reported revenue of ₹2,527.18 crore at a 23% EBITDA margin. Plant utilisation ran above 80% in Q1 FY27, when revenue grew 15% YoY to ₹709 crore at a 25% EBITDA margin despite raw material inflation linked to the Middle East conflict. Raw materials are the dominant cost line at 59% of FY26 revenue, with depreciation and capex together at over 22% of revenue, reflecting the capital intensity of the chemicals build-out. The board has approved ₹600 crore of new capex covering a 125,000 TPA epoxy resin and formulations plant and a multipurpose plant for chlorotoluene and epichlorohydrin derivatives, with pilot plants due by September 2025 and commercial commissioning targeted for H2 FY28. More than 50% of the raw material value for these projects will be sourced internally. Peak revenue from the new projects is sized at ₹1,300-1,500 crore, with total business peak revenue guided around ₹5,000 crore.
Measured from the filed financials, judged against its Specialty Chemicals peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from EPIGRAL LIMITED's filed financials and exchange disclosures
EPIGRAL LIMITED is a Chemicals & Petrochemicals company listed on NSE and BSE, trading under the symbol EPIGRAL.
Yes. Over the trailing twelve months EPIGRAL LIMITED reported a net profit of ₹271 Cr on revenue of ₹2,626 Cr.
Yes. The dividend yield is 0.37% at the current price. It paid out 6% of its profit as dividend in FY26.
No. Debt stands at 0.25× equity, and it carries net debt of ₹558 Cr. That is lower than 42% of its 101 Specialty Chemicals peers.
On trailing P/E, EPIGRAL LIMITED ranks 36 of 103 in Specialty Chemicals — cheaper than 66% of them, against an industry median of 23.4×. This is a position, not a valuation judgement.
On a typical session EPIGRAL LIMITED moves 1.33% — that is the median absolute close-to-close move across its last 268 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by EPIGRAL LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
